Navigating
Pharma Pricing
For pharma companies, the question is not
whether to react, but how. Here’s helpful
guidance for a constructive response.
WHAT IS LANGUAGE
STRATEGY®?
We find the exact words to make your audiences listen, care, and act. That’s how you win. That’s Language Strategy.
CONNECTING
WITH AUDIENCES
IS OUR BUSINESS
That’s why our speakers are in demand for conferences, keynotes, seminars, panels & more
WHEN YOU NEED
LANGUAGE STRATEGY
Through Language Strategy, maslansky+partners finds precisely the right words that can change behavior and move an audience to action when you need to…
maslansky+partners has worked with a range of companies, from multi-national brands to start-ups.
OUR LATEST INSIGHTS
Insights
Talking Tariffs: How Companies Can Communicate Effectively in a No-Win Situation
As the Trump administration fights over the future of its tariffs in the courts, companies are anxiously considering how to deal with this massive shift in U.S. trade policy. Many companies are asking us: what’s the right language and framing to talk about tariffs in a way that protects our business without antagonizing Washington? Michael Maslansky offers some sound advice for how to respond while mitigating the risk.
HearSay
The Pharma Dilemma: Trust, Pricing, and the New Language of Fairness
In this episode, Lee Carter is joined by Keith Yazmir and Katie Cronen to unpack why communicating effectively—especially in industries like pharma—is harder than ever. They explore how fairness, not goodness, is now the key to resonating with audiences, especially when discussing sensitive topics like drug pricing, health equity, and scientific trust… with practical strategies for corporate communicators to respond with transparency, empathy, and clarity.